Acute myopericarditis and left shoulder capsulitis following second dose of mRNA SARS-CoV-2 Moderna vaccination.

Détails

ID Serval
serval:BIB_5517E166C44E
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Acute myopericarditis and left shoulder capsulitis following second dose of mRNA SARS-CoV-2 Moderna vaccination.
Périodique
BMJ case reports
Auteur⸱e⸱s
Quinodoz A., Luthi F., Revaz S., Konzelmann M.
ISSN
1757-790X (Electronic)
ISSN-L
1757-790X
Statut éditorial
Publié
Date de publication
01/06/2023
Peer-reviewed
Oui
Volume
16
Numéro
6
Pages
e254110
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: epublish
Résumé
Vaccination against mRNA SARS-CoV-2 has been administered on a very large scale and various side effects have been described. The increased risk of myopericarditis is known, and only a few cases of shoulder capsulitis have been reported after vaccination. These two pathologies have never been reported in the same patient after vaccination. Our article presents the history of a man in his 40s who presented with myopericarditis a few days after vaccination against SARS-CoV-2 with mRNA(Messenger RNA) Moderna® vaccine and who at the same time developed shoulder capsulitis. His cardiovascular symptoms resolved rapidly, and his shoulder symptoms improved/resolved within 1 year. This case should make physicians aware of the possibility of several concomitant side effects following vaccination against SARS-CoV-2.
Mots-clé
Male, Humans, SARS-CoV-2, Shoulder, COVID-19, Bursitis, Pericarditis/etiology, Myocarditis/diagnosis, Myocarditis/etiology, Vaccination/adverse effects, Drug-Related Side Effects and Adverse Reactions, RNA, Messenger, Musculoskeletal and joint disorders, Rehabilitation medicine, Stiff shoulder, Vaccination/immunisation
Pubmed
Web of science
Création de la notice
07/06/2023 12:37
Dernière modification de la notice
09/12/2023 8:03
Données d'usage